173 related articles for article (PubMed ID: 15338724)
1. Synovial sarcoma (SS): new perspectives supported by modern technology.
Llombart-Bosch A; Lopez-Guerrero JA; Peydro-Olaya A
Arkh Patol; 2002; 64(3):39-47. PubMed ID: 15338724
[TBL] [Abstract][Full Text] [Related]
2. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript.
Fligman I; Lonardo F; Jhanwar SC; Gerald WL; Woodruff J; Ladanyi M
Am J Pathol; 1995 Dec; 147(6):1592-9. PubMed ID: 7495284
[TBL] [Abstract][Full Text] [Related]
4. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases.
Coindre JM; Pelmus M; Hostein I; Lussan C; Bui BN; Guillou L
Cancer; 2003 Dec; 98(12):2700-7. PubMed ID: 14669292
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnosis of synovial sarcoma: RT-PCR detection of SYT-SSX1/2 fusion transcripts in paraffin-embedded tissue.
Tvrdík D; Povýsil C; Svatosová J; Dundr P
Med Sci Monit; 2005 Mar; 11(3):MT1-7. PubMed ID: 15735574
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of molecular and cytogenetic findings in synovial sarcoma.
Panagopoulos I; Mertens F; Isaksson M; Limon J; Gustafson P; Skytting B; Akerman M; Sciot R; Dal Cin P; Samson I; Iliszko M; Ryoe J; Dêbiec-Rychter M; Szadowska A; Brosjö O; Larsson O; Rydholm A; Mandahl N
Genes Chromosomes Cancer; 2001 Aug; 31(4):362-72. PubMed ID: 11433527
[TBL] [Abstract][Full Text] [Related]
7. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.
Nilsson G; Skytting B; Xie Y; Brodin B; Perfekt R; Mandahl N; Lundeberg J; Uhlén M; Larsson O
Cancer Res; 1999 Jul; 59(13):3180-4. PubMed ID: 10397263
[TBL] [Abstract][Full Text] [Related]
8. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
[TBL] [Abstract][Full Text] [Related]
9. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma.
Inagaki H; Nagasaka T; Otsuka T; Sugiura E; Nakashima N; Eimoto T
Mod Pathol; 2000 May; 13(5):482-8. PubMed ID: 10824918
[TBL] [Abstract][Full Text] [Related]
10. A novel type of SYT/SSX fusion: methodological and biological implications.
Törnkvist M; Brodin B; Bartolazzi A; Larsson O
Mod Pathol; 2002 Jun; 15(6):679-85. PubMed ID: 12065783
[TBL] [Abstract][Full Text] [Related]
11. SYT-SSX fusion genes in synovial sarcoma of the thorax.
Yano M; Toyooka S; Tsukuda K; Dote H; Morimoto Y; Ohata N; Ichimura K; Aoe M; Date H; Shimizu N
Lung Cancer; 2004 Jun; 44(3):391-7. PubMed ID: 15140553
[TBL] [Abstract][Full Text] [Related]
12. Are there geographical differences in the frequency of SYT-SSX1 and SYT-SSX2 chimeric transcripts in synovial sarcoma?
Koković I; Bracko M; Golouh R; Ligtenberg M; van Krieken HJ; Hudler P; Komel R
Cancer Detect Prev; 2004; 28(4):294-301. PubMed ID: 15350633
[TBL] [Abstract][Full Text] [Related]
13. Fusions of the SYT and SSX genes in synovial sarcoma.
Ladanyi M
Oncogene; 2001 Sep; 20(40):5755-62. PubMed ID: 11607825
[TBL] [Abstract][Full Text] [Related]
14. Primary pulmonary synovial sarcoma confirmed by molecular detection of SYT-SSX1 fusion gene transcripts: a case report and review of the literature.
Hosono T; Hironaka M; Kobayashi A; Yamasawa H; Bando M; Ohno S; Sohara Y; Sugiyama Y
Jpn J Clin Oncol; 2005 May; 35(5):274-9. PubMed ID: 15879502
[TBL] [Abstract][Full Text] [Related]
15. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.
Guillou L; Benhattar J; Bonichon F; Gallagher G; Terrier P; Stauffer E; Somerhausen Nde S; Michels JJ; Jundt G; Vince DR; Taylor S; Genevay M; Collin F; Trassard M; Coindre JM
J Clin Oncol; 2004 Oct; 22(20):4040-50. PubMed ID: 15364967
[TBL] [Abstract][Full Text] [Related]
16. Reverse transcription-polymerase chain reaction in situ hybridization for SYT-SSX fusion gene transcripts in synovial sarcomas.
Kawauchi S; Fukuda T; Chochi Y; Kondo T; Oga A; Sasaki K
Int J Mol Med; 2005 Oct; 16(4):763-6. PubMed ID: 16142418
[TBL] [Abstract][Full Text] [Related]
17. Cryptic chromosome rearrangement resulting in SYT-SSX2 fusion gene in a monophasic synovial sarcoma.
Torres L; Lisboa S; Cerveira N; Lopes JM; Lopes C; Teixeira MR
Cancer Genet Cytogenet; 2008 Nov; 187(1):45-9. PubMed ID: 18992642
[TBL] [Abstract][Full Text] [Related]
18. Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas.
Yang K; Lui WO; Xie Y; Zhang A; Skytting B; Mandahl N; Larsson C; Larsson O
Oncogene; 2002 Jun; 21(26):4181-90. PubMed ID: 12037676
[TBL] [Abstract][Full Text] [Related]
19. Molecular analyses, morphology and immunohistochemistry together differentiate pleural synovial sarcomas from mesotheliomas: clinical implications.
Carbone M; Rizzo P; Powers A; Bocchetta M; Fresco R; Krausz T
Anticancer Res; 2002; 22(6B):3443-8. PubMed ID: 12552937
[TBL] [Abstract][Full Text] [Related]
20. Dual colour fluorescence in situ hybridization to paraffin-embedded samples to deduce the presence of the der(X)t(X;18)(p11.2;q11.2) and involvement of either the SSX1 or SSX2 gene: a diagnostic and prognostic aid for synovial sarcoma.
Lu YJ; Birdsall S; Summersgill B; Smedley D; Osin P; Fisher C; Shipley J
J Pathol; 1999 Mar; 187(4):490-6. PubMed ID: 10398111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]